Baseline neutrophil–lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer

The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer

(2016) Solange Peters et al.   CANCER TREATMENT REVIEWS

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

(2016) Arnoud J. Templeton et al.   EUROPEAN UROLOGY

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

(2016) Bob T. Li et al.   PLoS One

The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis

(2016) Adem Kucuk et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study

(2016) Seung Jun Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma

(2015) J. Zaragoza et al.   BRITISH JOURNAL OF DERMATOLOGY

EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan

(2015) Jian Guan et al.   MEDICAL ONCOLOGY

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

(2015) Seth B. Coffelt et al.   NATURE

Computed tomography-guided 125I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases

(2015) Hai Huang et al.   World Journal of Surgical Oncology

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

(2014) D. Lorente et al.   ANNALS OF ONCOLOGY

Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?

(2014) Turgut Kacan et al.   Asian Pacific Journal of Cancer Prevention

Strategies to Prevent Brain Metastasis in High-Risk Non–Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation

(2014) D. Hunter Boggs et al.   Clinical Lung Cancer

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) Arnoud J. Templeton et al.   JNCI-Journal of the National Cancer Institute

Clinical significance of the neutrophil–lymphocyte ratio in venous thromboembolism patients with lung cancer

(2014) Se-Il Go et al.   LUNG CANCER

Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting

(2014) Young Wha Koh et al.   TUMOR BIOLOGY

Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study

(2014) Kemal Gungorduk et al.   Cancer Research and Treatment

Epidermal growth factor receptor mutations in lung adenocarcinoma

(2013) Markus D Siegelin et al.   LABORATORY INVESTIGATION

Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

(2013) Jiaqiang Dan et al.   PLoS One

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

(2012) S. Cedrés et al.   Clinical & Translational Oncology

Protumor and antitumor functions of neutrophil granulocytes

(2012) Sven Brandau et al.   Seminars in Immunopathology

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

(2011) M J M Gooden et al.   BRITISH JOURNAL OF CANCER

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

(2011) W Chua et al.   BRITISH JOURNAL OF CANCER

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

(2011) Takehito Shukuya et al.   CANCER SCIENCE

Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma

(2011) Yoshio Ohno et al.   JOURNAL OF UROLOGY

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

(2010) Elizabeth M. Gore et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma

(2010) Dong-Ming Kuang et al.   JOURNAL OF HEPATOLOGY

Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma

(2010) Yoshio Ohno et al.   JOURNAL OF UROLOGY

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer

(2010) A. F. Eichler et al.   NEURO-ONCOLOGY

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors

(2009) M. Sun et al.   CLINICAL CANCER RESEARCH

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer

(2009) Campbell SD Roxburgh et al.   Future Oncology

Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer

(2009) Lorenzo Daniele et al.   Journal of Thoracic Oncology

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer

(2008) Khaled M. Sarraf et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY